XFOR X4 Pharmaceuticals Inc. Sof foyda normasi

X4 Pharmaceuticals Inc. (XFOR) - korporativ logo

X4 Pharmaceuticals (XFOR) kompaniyasining investitsiya potentsiali uning birinchi dori vositasining bozorga muvaffaqiyatli chiqarilishiga bog'liq bo'lib, bunda daromadlar bilan bog'liq noaniqliklar ma'lum xatarlarni yuzaga keltirmoqda. Joriy savdo marjasi darajasi biznesning qarz mablag'lari xarajatlariga moslashuvini ko'rsatadi, -474.70 esa ushbu ko'rsatkichning bazaviy qiymatini aks ettiradi. Kam uchraydigan patologiyalar terapiyalariga bo'lgan barqaror talab uzoq muddatli monopoliyani kafolatlaydi, og'iz orqali qabul qilinadigan CXCR4 ingibitorlarining yetuk loyihalari portfeli esa kompaniyaning texnologik tayyorgarligini tasdiqlaydi.

Sotuvning sof marjinal rentabelligi: X4 Pharmaceuticals (XFOR) 04.07.2022 - 19.11.2026 uchun

X4 Pharmaceuticals, Inc (XFOR) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:x4pharma.com, XFOR
X4 Pharma yetakchi tovari

Sotuv marjalari daromadning har bir dollari ichidagi sof foyda ulushini belgilab, xarajatlarni boshqarish samaradorligini ko'rsatadi. Ushbu ko'rsatkich operatsion xarajatlar va soliqlarni umumlashtirib, joriy sof foyda marjalari orqali biznesning yakuniy rentabelligini aks ettiradi. Ushbu metrikaning noldan pastga tushishi kritik yo'qotishlar va kapital xavfi haqida ogohlantiradi. X4 Pharmaceuticals (XFOR) uchun ushbu metrika Xolremdi ning tijorat ishga tushirilishi davrida asosiy ahamiyatga ega bo'ladi. Rentabellikning oshishi CXCR4 inhibitorlari pipeline'ining muvaffaqiyatli kengayganini tasdiqlaydi.

Raqobatchilar tahlili

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|Sotuvning sof marjinal rentabelligi ACET|Sof foyda bo'yicha sotuv rentabelligi Celularity Corp CELU|INmune Bio Inc - Sof foyda bo'yicha sotuv rentabelligi|BRNS (Barinthus Bio) - Sof foyda marjasi|KZR - Sof marja|Kompaniya sotuv marjasi sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Sof marja|ENLV - Kompaniya sotuv marjasi|QTTB (Q32 Bio) - Sotuvning sof marjinal rentabelligi|Sof marja GeoVax Labs Inc GOVX|Sof marja Edesa Biotech (EDSA)|Sof foyda bo'yicha sotuv rentabelligi iBio IBIO|Carisma Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|XTLB - Sof foyda bo'yicha sotuv rentabelligi|BOLT - Sof marja|Sof foyda normasi HCWB (hcwbiologics.com)|APVO: Sotuvning sof marjinal rentabelligi|aimimmuno.com (AIM) - Sotuvning sof marjinal rentabelligi|Sof marja aditxt.com|Sof foyda bo'yicha sotuv rentabelligi GRI Bio Corp (GRI)|Sof marja XORTX Therapeutics Inc. (XRTX)|Sof foyda bo'yicha sotuv rentabelligi ReShape Lifesciences HIND|Sof marja Revelation Biosciences REVB|INDP: Sotuvning sof rentabelligi|SCNI - Sof marja|CALI (calcimedica.com) - Sotuvning sof rentabelligi|AFMD (Affimed Therapeutics) - Sof foyda bo'yicha sotuv rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi